Deep Insights from the Experts
Growth Advisory
Technology | IP Research & Intelligence
Investment Research & Analytics
Valuation & Financial Advisory
For years, European medical device companies have largely built their evidence strategies around regulatory approval, clinical adoption, and country specific reimbursement. The EU Health Technology Assessment Regulation is beginning to disrupt this sequence. As selected ...read more
published on Oct 27, 2026
Multi-cancer blood tests will become routine only when four things happen in order: evidence that moves from detecting cancer to improving treatment outcomes, a payment pathway that turns a self-pay test into a covered benefit, ...read more
published on Oct 27, 2026
Smart textiles promise to turn health monitoring into a passive, continuous background function. Technology is maturing, but the industry’s real problem is not sensing; it is economics. A garment is washed, stretched, and eventually r ...read more
published on Oct 27, 2026
More than USD 300 billion in branded drug revenue will lose exclusivity by 2030, and big pharma is filling the gap on two tracks: paying full price for late-stage certainty and buying early assets as low-cost options. ...read more
published on Oct 27, 2026
Modern consumers prioritize food ingredients they trust and recognize with the aim of lowering sugar, salt, and fat content. Globally, there is growing demand for taste modulation solutions, driven by the expanding culinary and packaged ...read more
published on Apr 02, 2024
The government’s decision to install 100 million solar plants in Indian households would significantly boost the energy sector. This aligns with the Indian government’s global aspiration of “One Sun, One World, One Grid,” an initiat ...read more
published on Mar 01, 2024
GLP-1 agonists, led by Semaglutide, are reshaping metabolic disease management. Semaglutide boasts superior glycemic control, significant weight loss, and potential cardiovascular benefits, all in a convenient weekly injection. However, cost, side effects, injection delivery, and ...read more
published on Jan 23, 2024
Proactively navigating slow-moving technological changes is a vital strategic need for companies seeking sustained success in today’s dynamic business landscape. These changes, often gradual, have the power to shape or disrupt industries and companies, i ...read more
published on Jan 12, 2024
Selecting the right equities requires far more than tracking price momentum or following market sentiment. Institutional investors, whether managing long-only funds, hedge funds, or pension portfolios, depend on a disciplined understanding of a company's business ...read more
published on Aug 05, 2026
Fixed income portfolios depend on more than credit ratings alone. While rating agencies provide a useful starting point, institutional investors managing significant bond allocations require deeper, independent analysis to understand the true risk profile of ...read more
published on Aug 03, 2026
Volatility has become a permanent feature of global markets rather than an occasional disruption. Interest rate shifts, geopolitical conflict, inflation surprises, and supply chain shocks now arrive in rapid succession, forcing institutional investors to reassess ...read more
published on Jul 29, 2026
India’s new credit card issuance has expanded at a robust ~20% CAGR over the past five years, but the pace of growth has brought rising concerns around asset quality and consumer leverage. After a decade o ...read more
published on Dec 30, 2025
An audit-ready PPA report is not simply a correct valuation, it is a document structured so that an auditor reviewing it for the first time can assess every conclusion without needing to ask supplemental questions. ...read more
published on Aug 17, 2026
The fair value hierarchy determines what kind of evidence is used to value a financial instrument and how much professional judgment is required. For complex securities, understanding where an instrument sits in the hierarchy shapes ...read more
published on Aug 14, 2026
Independence in complex securities valuation is not a formality. It is the structural feature that makes a fair value conclusion credible to auditors, regulators, counterparties, and courts. It requires more than simply engaging an external ...read more
published on Aug 14, 2026
Goodwill is not simply the premium paid over book value. It is a specific accounting construct with a defined meaning, and understanding what it includes, what it excludes, and what a large goodwill balance signals ...read more
published on Aug 06, 2026
© , Aranca. All rights reserved.
